Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MEDI 493

Known as: Monoclonal Antibody MEDI-493, MEDI-493, Monoclonal Antibody, MEDI-493 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
We have identified a single tryptophan (Trp) residue responsible for loss of binding and biological activity upon ultraviolet (UV… Expand
Is this relevant?
Review
2000
Review
2000
Respiratory syncytial virus (RSV) is a common cause of respiratory illness in young children, almost all will have been infected… Expand
Is this relevant?
1999
1999
Two humanized monoclonal antibodies, MEDI-493 and RSHZ19, were developed independently as potential improvements over RSV-IGIV… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection in infants. MEDI-493… Expand
Is this relevant?
1998
1998
BACKGROUND Respiratory syncytial virus (RSV) is the leading cause of lower respiratory disease in infants and children. MEDI-493… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Thirty-five children <2 years of age mechanically ventilated for respiratory syncytial virus (RSV) infection were randomized to… Expand
Is this relevant?
1998
1998
Background.Respiratory syncytial virus (RSV) is the leading cause of lower respiratory disease in infants and children. MEDI-493… Expand
Is this relevant?
1998
1998
  • 1998
  • Corpus ID: 8799183
Objective. To determine the safety and efficacy of prophylaxis with palivizumab in reducing the incidence of hospitalization… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
1998
1998
MEDI-493, a humanized monoclonal antibody to the F-protein of RSV, is highly active against RSV. The objective of this study was… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Neutralizing polyclonal antibody to respiratory syncytial virus (RSV) has been shown to be an effective prophylactic agent when… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?